Optimapharm Lithuania UAB Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo dataIndicator |
---|
Turnover (€) |
Sales per employee (€) |
Profit before tax (€) |
Net Profit (€) |
Profit per employee (€) |
Total profitability (%) |
Net profitability (%) |
Equity (€) |
Amounts Payable And Liabilities (€) |
Non-current Assets (€) |
CurrentAssets (€) |
Working capital requirement |
Debt-to-equity ratio |
EBITDA margin (%) |
EBITDA (€) |
EBIT margin (%) |
EBIT (€) |
2022 |
---|
743,587 |
50,208 |
28,459 |
23,508 |
1,587 |
13.48 |
3.16 |
228,246 |
101,685 |
0 |
329,722 |
2023 |
---|
1,020,985 |
69,172 |
56,423 |
36,814 |
2,494 |
15.25 |
3.61 |
265,060 |
264,334 |
706 |
507,249 |
2024 |
---|
952,307 |
66,502 |
60,287 |
50,440 |
3,522 |
16.16 |
5.30 |
315,500 |
263,016 |
706 |
364,790 |
Register and
explore Okredo data2024 |
---|
952,307 |
66,502 |
60,287 |
50,440 |
3,522 |
16.16 |
5.30 |
315,500 |
263,016 |
706 |
364,790 |
Register and
explore Okredo data2024
Turnover (€)
952,307 €-7 % *
Sales per employee (€)
66,502 €-4 % *
Profit before tax (€)
60,287 €7 % *
Net Profit (€)
50,440 €37 % *
Profit per employee (€)
3,522 €41 % *
Total profitability (%)
16.16 %5.97 % *
Net profitability (%)
5.30 %46.81 % *
Equity (€)
315,500 €19 % *
Amounts Payable And Liabilities (€)
263,016 €-1 % *
Non-current Assets (€)
706 €0 % *
CurrentAssets (€)
364,790 €-28 % *